Gender Incongruence
13
7
7
1
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
7.7%
1 terminated out of 13 trials
50.0%
-36.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (13)
Swiss ProspectivE Cohort of TRAnsgender and Gender Diverse Individuals - The SPECTRA Study
MaPGAS Decision Making
Cardiomodulatory Effects of Gender-Affirming Hormone Therapy
Cardiovascular Health of Transgender Individuals During the Gender-affirming Pathway
The Copenhagen Gender Identity Cohort
China Gender-affirming Hormone Therapy Study
Optimizing Individual Health Care for Young People With Gender Incongruence
The Effect of Tucking on Semen Quality of Adult Trans Women
Effect of Transgender Therapy on Muscle, Fat and Tissue Receptors
Peritoneum Vaginoplasty; Implementation According to IDEAL Framework
Transgender In Transition
i2TransHealth: Interdisciplinary, Internet-based Trans Health Care
Sex Hormone Overdose and Misuse in Chinese Transgender and Gender Non-conforming Population